Author Archives: Rabita Aziz

50th Union World Conference on Lung Health: Socioeconomic support improves TB prevention

By on .

HYDERABAD, INDIA – Accelerating efforts to prevent tuberculosis wherever it is treated has been the rallying cry in Hyderabad during this conference. One study shows that providing financial incentives plus social support not only improves TB treatment completion but increases TB screening and preventative therapy uptake among household members of TB patients. “TB is the archetypal […]

50th Union World Conference on Lung Health: Prevention trial targets multidrug-resistant TB

By on .

HYDERABAD, INDIA – The National Institute of Allergy and Infectious Diseases is investing $70 million in a phase III clinical trial assessing the use of tuberculosis treatments in preventing multidrug-resistant tuberculosis infection among high-risk individuals, including infected household contacts of MDR-TB patients and people living with HIV, institute officials announced here. The trial will compare the […]

50th Union World Conference on Lung Health: TB drug price drop aims to accelerate access to improved preventive therapy

By on .

HYDERABAD, INDIA – A Global Fund to Fight AIDS, Tuberculosis and Malaria, Unitaid and pharmaceutical company agreement will reduce the price of a three-month course of rifapentine – a key drug used in preventive therapy against tuberculosis – by 66% in 100 low- and middle-income countries, officials from Unitaid and pharmaceutical company Sanofi announced here […]

50th Union World Conference on Lung Health: NIH announces $30 million for research to spur TB vaccine development

By on .

HYDERABAD, INDIA –  The National Institute of Allergy and Infectious Diseases will dedicate $30 million in new funding to accelerate development of new vaccines against tuberculosis. The announcement of the funding, which will be used to establish centers of immunology research at U.S. institutions, came during the same session researchers announced that for the first time […]

50th Union World Conference on Lung Health: Vaccine candidate shows effectiveness in preventing active TB disease

By on .

HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an investigational candidate showing 50% efficacy in preventing latent TB infection from progressing to active TB disease that was sustained three years after the start of the study. “We have […]

IDWeek 2019: Malnutrition is a major driver of TB epidemic globally

By on .

WASHINGTON, DC – Malnutrition is a significant risk factor for developing active tuberculosis disease, accounting for one quarter of all 1.6 million tuberculosis cases globally, while other risk factors like smoking and diabetes are attributed with 16% and 7.5% of infections respectively, researchers said here Tuesday. In spite of that, Dr. Natasha Hochberg of Boston […]

IAS 2019: Collapse of Venezuela’s health infrastructure dismantles HIV response

By on .

MEXICO CITY – A decade ago, Venezuela had one of the most progressive responses to its HIV epidemic in the world. In the 1990s the country’s Supreme Court mandated that the government provide lifesaving antiretroviral therapy, catalyzing a national HIV program which provided comprehensive care to everyone who qualified. Now, after more than five years […]

IAS 2019: Scientist highlights the weight of the smallest organism in HIV risk

By on .

MEXICO CITY – When you think of factors associated with increased risks of acquiring HIV, big pictures of marginalization, discrimination, geographic location, economic inequities and gender inequality might come to mind. With two maps here on Tuesday, a scientist zeroed in on a factor that, while literally microscopic, can also make a great difference: bacteria. On […]

IAS 2019: While dispelling concerns of DPM HIV risk, ECHO study yields data on STIs, PrEP interest, pregnancy rates

By on .

MEXICO CITY – Women using Depo Provera as a long acting, injectable hormonal contraceptive showed lower rates of sexually transmitted infection that include chlamydia and gonorrhea, during a study undertook with the primary aim of assessing whether the drug raised risks of HIV infection. This is one in several findings released Monday from the Evaluation of […]

IAS 2019: Data shows indigenous, nonbinary populations among those missed by HIV epidemic ending efforts

By on .

MEXICO CITY – Indigenous communities in the Americas are largely being left out of efforts to achieve UNAIDS’ global HIV elimination targets of 90 percent of people knowing their HIV status by 2020, 90 percent of people diagnosed with HIV accessing lifesaving antiretroviral therapy, and 90 percent of people on treatment achieving viral suppression, indigenous leaders […]